Critics argue that the Inflation Reduction Act is increasing costs and reducing patient access to medications through price negotiations and Medicare Part D restructuring. Â
USATimes247.com
USATimes247.com
Critics argue that the Inflation Reduction Act is increasing costs and reducing patient access to medications through price negotiations and Medicare Part D restructuring. Â
